Bacterial Pathogens and Diseases I (Exotoxins) Flashcards

1
Q

Pathogen - define

A

Pathogen: A microorganism capable of causing disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Pathogenicity - define

A

Pathogenicity: The ability of an infectious agent to cause disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Virulence - define

A

Virulence: The quantitative ability of an agent to cause disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Toxigenicity - define

A

Toxigenicity: The ability of a microorganism to produce a toxin that contributes to the development of disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Virulence – Mechanisms - list

A

Adherence Factors

Biofilms

Invasion of Host Cells and Tissues

Toxins – endotoxins and exotoxins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are exotoxins?

A

Heterogeneous group of proteins produced and secreted by living bacterial cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Exotins - produced by what

A

Produced by both gram negative and gram positive bacteria.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Exotins - effect

A

Cause disease symptoms in host during disease.

Cause disease? – may help transmission of disease, however in severe disease host may be a literal and evolutionary dead end.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Exotins - action

A

Act via a variety of diverse mechanisms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What selective advantages do exotoxins give to the bacteria?

A

With many toxins the disease causing activity may be not be the primary function.
Other activities:

Evade immune response
Enable biofilm formation
Enable attachment to host cells.
Escape from phagosomes

All allowing for colonisation, niche establishment and carriage - Evolutionary advantage.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Haemolytic toxins - effect, involved in which disease and give examples

A

Haemolytic toxins:

cause cells to lyse by forming pores

Important cause of features of S. aureus disease.

α,β,δ, toxins ,Panton Valentine Leukocidin (PVL), LukAB, LukED, LukMF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe genetic encoding of exotins

A

Can be encoded by chromosomal genes Shiga toxin in Shigella dysenteriae, TcdA & TcdB in C. difficile

Many toxins coded by extrachromosomal genes:

Plasmids – Bacillus anthracis toxin, tetanus toxin

Lysogenic bacteriophage – e.g. streptococcal pyrogenic exotoxins in Scarlet Fever, Diphtheria toxin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Classification of Exotoxins

A

As very diverse group of proteins and many ways to classify.
Classification can be by the toxins activity .

Membrane Acting Toxins – Type I
Membrane Damaging Toxins – Type II
Intracellular Toxins – Type III

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Problems with classification of Exotoxins

A

This classification has its problems –
Many toxins may have more than one type activity.
As mechanisms better understood this classification tends to break down.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Membrane Acting toxins – Type I, describe where they:

  • Act
  • Interfere
  • Target
A
  • Act = Act from without the cell.
  • Interfere = Interfere with host cell signaling by inappropriate activation of host cell receptors.
- Target = Target receptors include 
Guanylyl cyclase  → ↑  intracellular cGMP
Adenyl cyclase → ↑ intracellular cAMP
Rho proteins
Ras proteins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Membrane damaging toxins – type II - describe and explain action

A

Cause damage to the host cell membrane.

Insert channels into host cell membrane.
β sheet toxins e.g. S.aureus α – toxin, δ toxin, PVL
α helix toxins – e.g. diphtheria toxin
Enzymatical damage e.g. S. aureus β- haemolysin, PSM

OR

Receptor mediated

Receptor Independent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Membrane Damaging Toxins - describe action

A

Soluble monomer
Membrane associated monomer binding to specific receptor – ADAM10 - a sheddase a disintegrin and metalloproteinase
Nascent oligomer/pre pore complex
Membrane insertion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Intracellular toxins – type III - action

A

Active within the cell – must gain access to the cell

Usually 2 components – AB Toxins

  • Receptor binding and translocation function – B
  • Toxigenic (enzymatic) – A
  • May be single or multiple B units e.g. Cholera toxin AB5
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Enzymatic component A – wide variety of activities - List

A

Enzymatic component A – wide variety of activities.

ADP – ribosyl transferases - e.g. Exotoxin A of Pseudomonas aeruginosa, pertussis toxin.
Glucosyltransferases – e.g. TcdA and TcdB of Clostridium difficile
Deamidase – e.g. dermonecrotic toxin of Bordetella pertussis.
Protease – e.g. Clostridial neurotoxins: botulism & tetanus
Adenylcyclase - e.g. EF toxin of Bacillus anthracis

20
Q

Describe superantigen mech for exotoxins

A

Superantigen – non specific bridging of the MHC Class II and T- cell receptor leading to cytokine production. E.g. Staphylococcal Exfoliative Toxin A, Toxic Shock Syndrome Toxin 1 (TSST1)

21
Q

Describe inflammasome mech for exotoxins

A

Via activation of the different inflammasome leading to release IL1 β and IL18 e.g. S. aureus toxin A, PVL.

22
Q

Exotin relation to cytokine action - describe and list examples

A

Exotoxins are able to induce inflammatory cytokine release

IL1, IL1β, TNF, IL 6,δ interferon, IL18

23
Q

Toxins can be inactivated using

A

Toxins can be inactivated using formaldehyde or glutaraldehyde → toxoids

24
Q

What allows toxioids to form basis of vaccines - give examples

A

Toxoids are inactive proteins but still highly immunogenic – form the basis for vaccines.
Tetanus Vaccine
Diphtheria
Pertussis (acellular).*

25
Q

Treatment of toxin mediated disease can be affected by

A

Treatment of toxin mediated disease can be affected by administering preformed antibodies to the toxin:

Diphtheria antitoxin – horse antibodies.
Tetanus – pooled human immunoglobulin. Specific or normal.
Botulism – horse antibodies

26
Q

Clostridium difficile

(Clostridioides difficile) - describe microbiology

A

Microbiology:

gram-positive bacillus.
anaerobic.
spore-forming.
toxin-producing.
can be carried asymptomatically in the gut. 
3 toxins.
27
Q

Clostridium difficile

(Clostridioides difficile) - describe epidemiology

A

Epidemiology:

Common hospital acquired infection worldwide.
Spread by ingestion of spores – remain dormant in environment.
Coloniser of the human gut up to 5% in adults.
Risk factors – antibiotic use, age, antacids & prolonged hospital stay.

28
Q

Clostridium difficile – antibiotics - describe action

A

Thought to act by disrupting the microbial ecosystem within the gut.

29
Q

Clostridium difficile – antibiotics - benefits

A

Antibiotics provide a competitive advantage to spore forming anaerobes over non spore forming anaerobes.
Allows C. difficile colonisation and growth.

30
Q

Coding of Cytotoxin A

A

Cytotoxin A - TcdA coded by tcdA gene

31
Q

Coding of Cytotoxin B

A

Cytotoxin B – TcdB coded by tcdB gene

32
Q

The A component of toxins are

A

The A component of toxins are glycosylating enzymes.

33
Q

Clostridium difficile disease - characteristics

A

Asymptomatic

Watery Diarrhoea

Dysentery

Pseudomembranous Colitis

Toxic Megacolon and
Peritonitis

34
Q

Clostridium difficile disease - pathology

A

Cytopathic & Cytotoxic:

Patchy necrosis with neutrophil infiltration
Epithelial ulcers
Pseudomembranes – leucocytes, fibrin, mucous, cell debris.

35
Q

C. difficile - diagnosis

A

Clinical signs and symptoms
Raised white cell count in blood.

Detection of organisms and toxins in stool

2 phase test:

Glutamate dehydrogenase – detects if C. difficile organism present.
Toxin enzyme linked immunosorbent assay (ELISA) for TcdA and TcdB toxins.

Detection of tcdA and tcdb genes – PCR

Colonoscopy – pseudomembranous colitis

36
Q

C. difficile treatment

A

Treatment dependent on severity and presence of surgical complications
Ideally removal of offending antibiotic – not always possible
Antibiotics fidaxomicin or metronidazole or vancomycin
Surgery – partial, total colectomy
Recurrent – faecal transplant.

37
Q

Verocytotoxin Escherichia coli (VTEC) disease - effect

A

VTEC, or Shiga-toxin (Stx) producing E. coli (STEC) can cause disease mild to life threatening disease.

38
Q

Verocytotoxin Escherichia coli (VTEC) disease - presentation

A

Stx carried by some E. coli – most commonly O157:H7
Identified usually by growth on sorbitol MacConkey agar (SMac) – does not ferment sorbitol and hence is clear.
Other less common types not identified using SMac.

39
Q

Verocytotoxin Escherichia coli (VTEC) disease - describe epidemiology

A

E. coli O157:H7 naturally colonizes the gastrointestinal tracts of cattle who are generally asymptomatic.

Transmission:

Predominantly via consumption of contaminated food and water
Person to person, particularly in child day-care facilities, and from
Animal to person. E.g. in petting zoos, dairy farms, or camp grounds.

Very low infectious dose

40
Q

SLT - describe structure

A

Toxin – Shiga like toxin (SLT) = shigatoxin (Stx) = verocytotoxin (VTEC)
Stx, Stx1, Stx1a, 1c, 1d Stx2a, 2c, 2d – variations in a.a. sequence
Gene carried on lysogenic bacteria.
Type III exotoxin – AB5
Enzymatic component A = N-Glycosidase
Bound to 5 B subunits

41
Q

SLT - describe mechanism

A

Bind to receptor globotriaosylceramide Gb3 or globotetraosylceramide (Gb4) on host cell membrane

Bound toxin internalised by receptor mediated endocytosis.

Carried by retrograde trafficking via the Golgi apparatus to the endoplasmic reticulum.

The A subunit is cleaved off by membrane bound proteases

Once in the cytoplasm A1 and A2 disassociate

A1 binds to 28S RNA subunit – blocks protein synthesis.

42
Q

STEC - Pathogenesis

A

Closely adheres to epithelial cells of the gut mucosa.

Route from intestine to the kidney and other tissues is debated, possibly polymorphonuclear neutrophils (PMNs)

Bind to glomerular endothelial cells of kidney, cardiovascular and central nervous system.

Very high levels of Gb3 in kidney so kidneys most affected.

Thought that Stx favours inflammation resulting in microvascular thrombosis and inhibition of fibrinolysis.

43
Q

STEC Disease - characteristics

A
Can be severe and life threatening
Children < 5 years  greatest risk
Abdominal cramps, watery or bloody diarrhoea – may not be present 
Haemolytic uraemic syndrome
Less common are neurological symptoms
44
Q

Describe Haemolytic uraemic syndrome

A

Haemolytic uraemic syndrome
Anaemia
Renal Failure
Thrombocytopaenia

45
Q

STEC Diagnosis

A

Diagnosis:

Clinical signs and symptoms
Haematological and biochemical evidence.
Stool culture – Growth on SMac
PCR for Stx genes

46
Q

STEC Treatment

A

Treatment:

Supportive including renal dialysis and blood product transfusion
Antibiotics have little to no role